Results 161 to 170 of about 3,813 (208)

Renal function dynamics in COVID-19: exploring biomarker interactions with D-dimer and C-reactive proteins. [PDF]

Biosci Rep
Saha I, Sinha A, Kumar Sadhu A, Das RN, Ghosh S, Banerjee P, Banerjee O, Sarkar Biswas S, Mukherjee S, Pal PK.   +9 more
europepmc   +1 more source

Docosahexaenoic Acid and Its Metabolites Protect against Ozone-induced Pulmonary Inflammation. [PDF]

Am J Respir Cell Mol Biol
Yaeger MJ, Ngatikaura T, Zecchino N, Lovins HB, Schott E, Cochran SJ, Hutton G, Ray JL, Saunders B, Leuenberger LA, Kilburg-Basnyat B, Virk R, Van Duinen R, Mo X, Armstrong M, McFadden MI, Fenton JI, Reisdorph N, Forero A, Ballinger MN, Tighe RM, Shaikh SR, Gowdy KM.   +22 more
europepmc   +1 more source

Correction for Gobbetti et al., Protectin D1n-3 DPA and resolvin D5n-3 DPA are effectors of intestinal protection. [PDF]

Proc Natl Acad Sci U S A
europepmc   +1 more source

Intestinal flora composition and fecal metabolic phenotype in elderly patients with sleep disorders combined with type 2 diabetes. [PDF]

Aging Med (Milton)
Yin Z, Xie H, Liu F, Kong X, Chen W, Gong Y, Ge W.   +6 more
europepmc   +1 more source

Alox8 knockout exacerbates imiquimod-induced psoriasis-like inflammation. [PDF]

Cell Death Dis
Palmer MA, Kirchhoff R, Hahnefeld L, Thomas D, Elewa MAF, You X, Aliraj B, Benatzy Y, Weigert A, Schebb NH, Brüne B.   +10 more
europepmc   +1 more source

Synthetic Studies Towards Analogs Of Protectin D1

, 2016
openaire   +1 more source

Confusion between protectin D1 (PD1) and its isomer protectin DX (PDX). An overview on the dihydroxy-docosatrienes described to date [PDF]

Biochimie, 2014
There is currently a growing interest in docosahexaenoic acid (DHA) oxygenated metabolites. Among them, protectin D1 (PD1), an endogenous dihydroxylated and non-cyclic docosatriene made through lipoxygenation and hydrolysis of an epoxide intermediate, shows appealing biological effects.
Thierry Durand, Laurence Balas, Michel Lagarde   +2 more
exaly   +6 more sources

Survival of Helicobacter pylori from complement lysis by binding of GPI-anchored protectin (CD59) [PDF]

Gastroenterology, 2001
Background & Aims: Although Helicobacter pylori is sensitive to complement lysis in vitro, chronic infection persists for years. We tested whether H. pylori acquires complement resistance by binding glycolipid-tailed inhibitors from the host. Methods:
Seppo Kalevi Meri, Arto Kokkola, Pauli Puolakkainen   +2 more
exaly   +2 more sources